
|Articles|August 2, 2002
- Pharmaceutical Technology-08-02-2002
- Volume 26
- Issue 8
Risk Management Shapes FDA Policies and Practices
Author(s)Jill Wechsler
In response to increasing concern about drug safety, FDA has implemented several administrative and policy changes, inclduing the new Office of Pharmacoepidemiology and Statistical Science and a renewed focus on risk assessment.
Advertisement
Articles in this issue
about 24 years ago
Packaging Advances ShowcasedAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
GSDIa Gene Therapy Approval Signals New Path for Rare Disease Manufacturing
2
Ask the Expert: Complying with Standards
3
How the Nitrosamine Guidance Shift is Changing LC-MS Workflows for APIs and Peptides
4
Q&A: Why Sponsors Are Turning to Mixed FSP/FSO Models
5




